{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:20:09Z","timestamp":1787779209894,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2019GSF107037"],"award-info":[{"award-number":["2019GSF107037"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MC168"],"award-info":[{"award-number":["ZR2023MC168"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.biomaterials.2026.124435","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:54:00Z","timestamp":1783781640000},"page":"124435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor microenvironment-responsive self-assembling nanotherapeutics integrating chemo-, anti-angiogenic, and immunostimulatory therapy for triple-negative breast cancer"],"prefix":"10.1016","volume":"336","author":[{"given":"Weihong","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxiao","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-151X","authenticated-orcid":false,"given":"Jianye","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-8966","authenticated-orcid":false,"given":"Chunying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124435_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41467-022-28452-z","article-title":"Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124435_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216846","article-title":"Immunogenic cell death inducers: current advances and future perspectives","volume":"542","author":"Lv","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124435_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s43018-022-00339-4","article-title":"LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer","volume":"3","author":"P\u00e9rez-N\u00fa\u00f1ez","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124435_bib5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamaoncol.2020.2965","article-title":"Effect of adjuvant paclitaxel and carboplatin on survival in women with triple-negative breast cancer: a phase 3 randomized clinical trial","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124435_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1950","article-title":"Nanoparticle drug delivery systems responsive to tumor microenvironment: promising alternatives in the treatment of triple-negative breast cancer","volume":"16","author":"Cao","year":"2024","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2023.101070","article-title":"Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer","volume":"134","author":"Kong","year":"2023","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.biomaterials.2026.124435_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s12885-016-2937-2","article-title":"Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies","volume":"16","author":"Nobrega","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biomaterials.2026.124435_bib11","article-title":"Identification of LRG1 targeting peptide and its application in targeted imaging for breast cancer","author":"Chen","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.biomaterials.2026.124435_bib12","article-title":"Targeted drug delivery systems mediated by a novel peptide in breast cancer therapy and imaging","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2026.124435_bib13","article-title":"Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy","volume":"1878","author":"Yu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.biomaterials.2026.124435_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2026.124435_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124435_bib16","article-title":"Fibroblast activation protein-\u03b1 responsive peptide assembling prodrug nanoparticles for remodeling the immunosuppressive microenvironment and boosting cancer immunotherapy","volume":"18","author":"Sun","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124435_bib17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1021\/acsmedchemlett.9b00191","article-title":"Novel small molecule-derived, highly selective substrates for fibroblast activation protein (FAP)","volume":"10","author":"De Decker","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biomaterials.2026.124435_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1307860","article-title":"Recent advances of anti-angiogenic inhibitors targeting VEGF\/VEGFR axis","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.ijbiomac.2022.09.129","article-title":"A concise review of VEGF, PDGF, FGF, notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions","volume":"221","author":"Vimalraj","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41420-022-01198-9","article-title":"A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124435_bib21","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1158\/1078-0432.CCR-04-2162","article-title":"Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination","volume":"11","author":"Lunt","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124435_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202502075","article-title":"Hip-targeted delivery of bFGF platform with dual modulation for enhancing neurovascular repair in traumatic brain injury","author":"Nie","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124435_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Defining cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124435_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-019-1897-5","article-title":"TGF-\u03b2 orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1","volume":"577","author":"Su","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124435_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41392-022-01132-6","article-title":"Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis","volume":"7","author":"Jinesh","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124435_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.devcel.2025.01.016","article-title":"Vimentin intermediate filaments coordinate actin stress fibers and podosomes to determine the extracellular matrix degradation by macrophages","volume":"60","author":"Huang","year":"2025","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biomaterials.2026.124435_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13058-025-02072-z","article-title":"MSN\/STAT3 drives cancer stemness and chemoresistance via IL-6\/LPAR1 ligand receptor complex in triple-negative breast cancer","volume":"27","author":"Lee","year":"2025","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124435_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib30","article-title":"Construction of in situ personalized cancer vaccines by bioorthogonal catalytic microneedles for augmented melanoma immunotherapy","volume":"21","author":"Xu","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124435_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","author":"Leon-Ferre","year":"2023","journal-title":"Br. Med. J."},{"key":"10.1016\/j.biomaterials.2026.124435_bib32","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/acs.accounts.9b00283","article-title":"Smart nanotherapeutic targeting of tumor vasculature","volume":"52","author":"Li","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2026.124435_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biomaterials.2026.124435_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202510010","article-title":"Tumor microenvironment-activated Fe3+-doped dendritic mesoporous organosilica nanocomposites as ferroptosis inducers for enhanced immunotherapy","author":"Feng","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124435_bib35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124435_bib36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.7150\/thno.103636","article-title":"Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy","volume":"15","author":"Shao","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2026.124435_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101766","article-title":"Engineered drug delivery nanosystems for tumor microenvironment normalization therapy","volume":"49","author":"Yang","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124435_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41565-025-01857-9","article-title":"Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy","volume":"20","author":"Zhang","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib39","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1002\/adma.201505869","article-title":"Light-activated hypoxia-responsive nanocarriers for enhanced anticancer therapy","volume":"28","author":"Qian","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124435_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305798","article-title":"Self-adaptive nanoregulator to mitigate dynamic immune evasion of pancreatic cancer","volume":"35","author":"Pan","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124435_bib41","article-title":"Linking tumour angiogenesis and tumour immunity","author":"Kabir","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13009","article-title":"Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biomaterials.2026.124435_bib43","doi-asserted-by":"crossref","first-page":"30943","DOI":"10.1021\/acsnano.3c12967","article-title":"Tumor-derived extracellular vesicles enable tumor tropism chemo-genotherapy for local immune activation in triple-negative breast cancer","volume":"18","author":"Peng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124435_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117637","article-title":"Plant-derived extracellular vesicles release combined with systemic DOX exhibits synergistic effects in 3D bioprinted triple-negative breast cancer","volume":"181","author":"Cui","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2026.124435_bib48","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124435_bib49","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2026.124435_bib47","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.3390\/ijms22073765","article-title":"Anti-angiogenic therapy: current challenges and future perspectives","volume":"22","author":"Lopes-Coelho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124435_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111548","article-title":"The role of dendritic cells in cancer immunity and therapeutic strategies","volume":"128","author":"Tai","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biomaterials.2026.124435_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn9083","article-title":"In vivo dendritic cell reprogramming for cancer immunotherapy","volume":"386","author":"Ascic","year":"2024","journal-title":"Science"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122600459X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122600459X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:46:03Z","timestamp":1787777163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296122600459X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":48,"alternative-id":["S014296122600459X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124435","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor microenvironment-responsive self-assembling nanotherapeutics integrating chemo-, anti-angiogenic, and immunostimulatory therapy for triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124435"}}